John F. Neylan, See Remarks at Angion Biomedica Corp. (ANGN), sold 381 shares at $9.03 ($3K) on 2021-08-18, disclosed to the SEC on 2021-08-19.
Scheduled sale ($3k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANGN | SELL | 2021-10-20 | $3K | — | Filing → |
| ANGN | SELL | 2021-09-21 | $4K | — | Filing → |
| ANGN | SELL | 2021-07-22 | $4K | — | Filing → |